DALLE CARBONARE, L.; BERTOLDO, F.; LO CASCIO, V. Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project. Reumatismo, v. 61, n. 1, p. 54-64, 11.